Come up with a name for your new list and we'll add to it:
Theron Pharmaceuticals raised a round of funding on January 10, 2011. Investors include
Life Science Angels.
Theron Pharmaceuticals is a preclinical stage biotechnology company developing an M3 muscarinic antagonist (LAMA) targeting chronic obstructive pulmonary disease (COPD) and asthma markets.…